Switch to:
More From Other Websites
Superbugs Turn Big Pharma, Gov't Focus To Antibiotics Apr 09 2015
Mario Gabelli's Top 5 Stock Picks Mar 31 2015
Farallon Capital Starts New Position in Cubist Pharmaceuticals Mar 20 2015
Elliott Management exits position in Covidien Mar 04 2015
Elliott Management starts new position in Cubist Pharmaceuticals Mar 02 2015
Prem Watsa's Stock Buys and Sells of Q4 Feb 17 2015
Dana Holding Set to Join the S&P MidCap 400 Jan 20 2015
Cubist Announces Withdrawal of Listing of CVRs (CBSTZ) from NASDAQ Global Select Market Jan 13 2015
Teixobactin And iChip Promise Hope Against Antibiotic Resistance Jan 08 2015
Cramer's Mad Dash: Pharma movers Dec 24 2014
FDA Approves Second Cubist Antibiotic Of 2014 Dec 19 2014
Cubist Announces FDA Approval of New Antibiotic ZERBAXA™ (Ceftolozane/Tazobactam) for Complicated... Dec 19 2014
FDA approves Cubists' drug for antibiotic-resistant bacteria Dec 19 2014
Merck Begins Tender Offer to Acquire Cubist Dec 19 2014
$100 trillion Superbugs threat Dec 18 2014
Tetraphase Jumps As 'Superbug' Drug Scores In Trial Dec 18 2014
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Cubist... Dec 15 2014
SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Cubist... Dec 12 2014
CBST SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches Investigation of the Board of... Dec 12 2014
CUBIST PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of... Dec 11 2014

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership